# Parker Institute for Cancer Immunotherapy

> facility in San Francisco, United States

**Wikidata**: [Q50035640](https://www.wikidata.org/wiki/Q50035640)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Parker_Institute_for_Cancer_Immunotherapy)  
**Source**: https://4ort.xyz/entity/parker-institute-for-cancer-immunotherapy

## Summary
The Parker Institute for Cancer Immunotherapy is a research facility in San Francisco, United States, founded in 2016 by entrepreneur Sean Parker, focused on cancer immunotherapy research.

## Key Facts
- Founded in 2016 by Sean Parker
- Located in San Francisco, United States
- Field of work: cancer immunotherapy
- Website: https://www.parkerici.org/
- Twitter handle: @parkerici (verified account with 10,078 followers as of 2022-10-04)
- Facebook page: ParkerICI
- LinkedIn page: parker-institute-for-cancer-immunotherapy
- Coordinates: 37.799386 latitude, -122.449292 longitude
- Named after its founder Sean Parker
- Research institute focused on cancer immunotherapy

## FAQs
### Q: What is the Parker Institute for Cancer Immunotherapy?
A: It is a research facility in San Francisco founded in 2016 by Sean Parker, focused on cancer immunotherapy research.

### Q: Who founded the Parker Institute?
A: The institute was founded by Sean Parker, an American entrepreneur and philanthropist.

### Q: Where is the Parker Institute located?
A: It is located in San Francisco, United States.

### Q: What is the institute's main focus?
A: The Parker Institute focuses on cancer immunotherapy research.

## Why It Matters
The Parker Institute for Cancer Immunotherapy represents a significant advancement in cancer research by bringing together leading scientists and institutions to accelerate the development of immunotherapies. By focusing specifically on cancer immunotherapy, the institute addresses a critical challenge in oncology - developing treatments that harness the body's immune system to fight cancer. Its establishment in 2016 marked a major investment in collaborative research, aiming to accelerate breakthroughs that could transform cancer treatment and improve patient outcomes. The institute's approach to interdisciplinary collaboration and its focus on translating research into clinical applications make it particularly impactful in the field of oncology.

## Notable For
- Founded by tech entrepreneur Sean Parker, leveraging his philanthropic resources to support cancer research
- Specializes exclusively in cancer immunotherapy, focusing on developing innovative treatments that harness the immune system
- Maintains a verified Twitter account (@parkerici) with over 10,000 followers as of 2022
- Operates as a research facility in San Francisco, positioned to leverage the city's strong biomedical research ecosystem
- Named after its founder, creating a direct connection between the philanthropic initiative and the research institution

### History and Development
The Parker Institute was established in 2016 with the goal of accelerating cancer immunotherapy research. Founded by Sean Parker, it represents a significant philanthropic investment in cancer research. The institute operates as a research facility located in San Francisco, leveraging the city's strong biomedical research infrastructure. Its inception marked a shift toward collaborative research approaches in oncology, bringing together leading scientists and institutions to work on breakthrough treatments.

### Research Focus
The institute's primary field of work is cancer immunotherapy, which involves developing treatments that stimulate or enhance the body's immune system to recognize and attack cancer cells. This approach represents a major advancement in cancer treatment, offering potentially more effective and less toxic alternatives to traditional chemotherapy and radiation therapies.

### Organizational Structure
As a research institute, the Parker Institute operates as a facility dedicated to scientific research rather than direct patient care. It maintains a presence in San Francisco and utilizes various digital platforms including a website (https://www.parkerici.org/), Twitter (@parkerici), Facebook (ParkerICI), and LinkedIn (parker-institute-for-cancer-immunotherapy) for communication and engagement with the scientific community and public.

### Impact and Goals
The institute's mission is to accelerate the development of cancer immunotherapies through collaborative research. By focusing on this specific area of oncology, it aims to address the significant unmet need for more effective cancer treatments. The organization's approach to interdisciplinary collaboration and its connection to the broader biomedical research ecosystem in San Francisco position it as a key player in advancing cancer immunotherapy research.

## References

1. GRID Release 2018-02-08